FNDC5 and type 2 diabetes mellitus: Similar to irisin, reduced adropin levels have been linked to such metabolic conditions as T2DM, IR [20], hepatic steatosis [18], polycystic ovary syndrome [21], metabolic syndrome [22], and obesity [23].